Our laboratory is developing into two directions. The first direction is to dissect signal transduction pathways or large protein complexes with a combination of structural determination by X-ray crystallography and molecular and cellular studies. The second direction is the structure-based drug design . We aim to design small molecules to dissect cell regulation with chemical genetics. Specific inhibitors of enzymes or protein complexes could also be useful for therapeutics.